Concepedia

Marielle Andersson

MA

Statistics

Publications

8

Citations

756

H-Index

8

Active since

1995

Affiliations

AstraZeneca (Sweden)(Current)

Harvard University

McMaster University

Hôpital Bichat-Claude-Bernard

Royal Brompton Hospital

Marielle Andersson is an author at AstraZeneca (Sweden) specializing in medicine, coronary artery disease, and antiplatelet therapy.

Publications per year

1995–2024

8

Publications

8

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Philippe Gabríel Steg, Deepak L. Bhatt, Tabassome Simon et al. · New England Journal of Medicine · 2019 · 362 citations · Full text

, , +17

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

, , +15

Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study

Carl Johan Malm, Emma C. Hansson, Jan‐Åke Åkesson et al. · British Journal of Anaesthesia · 2016 · 98 citations · Full text

, , +17

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

Deepak L. Bhatt, Kim Fox, Robert A. Harrington et al. · Clinical Cardiology · 2019 · 26 citations · Full text

, , +17

Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study

Matthew M. Heeney, Miguel R. Abboud, Jessie Githanga et al. · Blood · 2022 · 23 citations · Full text

, , +17

1–5 of 8